Sørensen E V, Jensen H K, Faergeman O
Department of Internal Medicine and Cardiology, Aarhus Amtssygehus, Denmark.
Eur J Clin Pharmacol. 1991;41(1):51-5. doi: 10.1007/BF00280106.
The influence of clinical doses of drugs that affect beta-adrenoceptors has been examined on heart rate, blood pressure, duration of exercise, and on electrolyte concentrations (Na, K, Ca and Mg) during recovery from exercise in healthy volunteers. The drugs used were a beta 1-adrenoceptor antagonist atenolol, a nonselective beta-adrenoceptor antagonist propranolol, and a cardioselective, partial beta 1-adrenoceptor agonist with 43% ISA activity, xamoterol. The duration of exercise was smaller on propranolol. Maximum exercise heart rate and blood pressure were reduced significantly by propranolol and atenolol. Xamoterol reduced maximum exercise heart rate and had no effect on blood pressure. The degree of breathlessness and fatigue revealed no differences between treatments. Recent evidence has suggested an association between hyperkalaemia and hypomagnesaemia with an increase in the occurrence of arrythmias following acute myocardial infarction. Exercise-induced hyperkalaemia has been suggested as a factor in sudden death. The results confirmed a rise in serum potassium during exercise and attenuation of the fall during recovery under beta-adrenoceptor blockade. Xamoterol was no different from placebo in these respects. Exercise also produced a rise in magnesium levels and during recovery the level fell below baseline. Both these effects were attenuated by propranolol. Calcium levels were not affected by any of the treatments.
研究了临床剂量下影响β-肾上腺素能受体的药物对健康志愿者运动恢复过程中心率、血压、运动持续时间以及电解质浓度(钠、钾、钙和镁)的影响。所用药物为β1-肾上腺素能受体拮抗剂阿替洛尔、非选择性β-肾上腺素能受体拮抗剂普萘洛尔以及具有43%内在拟交感活性的心脏选择性、部分β1-肾上腺素能受体激动剂扎莫特罗。服用普萘洛尔后运动持续时间缩短。普萘洛尔和阿替洛尔显著降低了最大运动心率和血压。扎莫特罗降低了最大运动心率,但对血压无影响。呼吸困难和疲劳程度在各治疗组之间无差异。最近的证据表明,高钾血症和低镁血症之间存在关联,急性心肌梗死后心律失常的发生率会增加。运动诱发的高钾血症被认为是猝死的一个因素。结果证实,运动期间血清钾升高,在β-肾上腺素能受体阻滞剂作用下恢复过程中下降幅度减小。在这些方面,扎莫特罗与安慰剂无差异。运动还使镁水平升高,恢复期间该水平降至基线以下。这两种效应均被普萘洛尔减弱。钙水平不受任何治疗的影响。